Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Case Reports in Oncology|February 28, 2014
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysisGiovanna Tabellini, Marzia Benassi, Emanuela Marcenaro, et al.Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.Frontiers in Immunology|August 10, 2019
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary ImmunodeficienciesGiovanna Tabellini, Ornella Patrizi, Kerry Dobbs, et al.Oncoimmunology|July 3, 2015
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escapeSilvia Pesce, Giovanna Tabellini, Claudia Cantoni, et al.Clinical Immunology (Orlando, Fla.)|March 12, 2022
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent mannerOrnella Patrizi, Manuela Baronio, Luisa Gazzurelli, et al.International Immunopharmacology|November 30, 2013
Effects of opioid therapy on human natural killer cellsGiovanna Tabellini, Elisa Borsani, Marzia Benassi, et al.Clinical Immunology (Orlando, Fla.)|December 8, 2016
NFKB1 regulates human NK cell maturation and effector functionsVassilios Lougaris, Ornella Patrizi, Manuela Baronio, et al.Plos One|December 5, 2013
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defectsLuisa Lorenzi, Giovanna Tabellini, William Vermi, et al.The Journal of Allergy and Clinical Immunology|January 11, 2017
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutationsGiovanna Tabellini, Donatella Vairo, Omar Scomodon, et al.Pageof 2